+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast - 2027

  • ID: 4619813
  • Drug Pipelines
  • September 2018
  • Region: Global
  • 180 Pages
  • DelveInsight
1 of 2

“Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast - 2027” report provides an overview of the disease pathogenesis, Biomarkers, various diagnostic approaches and treatment algorithm including detailed chapters for marketed products and various marketed products patent details. The report also includes in depth research related to Phototherapies for Psoriasis for the 7MM including United States, EU-5 (Germany, France, Italy, Spain and UK) and Rest of the world for the study period undertaken from 2015-2027.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Rest of the world

Study Period: 2016-2027

Phototherapies for Psoriasis Understanding and Treatment

The report provides the in depth analysis of the disease overview by providing details such as disease definition, symptoms, causes, pathogenesis, biomarkers, co-morbid conditions with psoriasis, different diagnostic approaches and guidelines of various regulatory bodies to treat and manage the psoriasis and treatment algorithm are also provided in the report.

Psoriasis is fundamentally an inflammatory skin condition with reactive abnormal epidermal differentiation and hyperproliferation which affects 2-3% of the world’s population. The pathophysiology of the disease includes mainly the activation and migration of T-cells to the dermis triggering the release of cytokines (tumor necrosis factor-alpha, TNF-alpha in particular) which lead to the inflammation and the rapid production of skin cells. A number of factors are responsible for triggering psoriasis. Among factors known to induce or worsen psoriasis are: mild localized trauma, such as scratching, piercings, tattoos, sunburns, chemical irritant, drugs including beta-blockers, lithium, anti-malarials, and non-steroidal anti-inflammatory drugs, HIV infection, and Stereptococcal pharyngitis. The climate in general and exposure to natural sun light in particular act as additional extrinsic factors with clinically important impacts on disease activity. Another factor of central importance is genetics.

Psoriasis Epidemiology Insights

This section provides the insights into the historical and current patient pool and forecasted trend segmented by 7 major markets. It enables understanding of the historical and forecasted epidemiological data for the prevalent cases of Psoriasis. Across 7MM, Psoriasis prevalent cases demonstrated an increasing trend and are forecasted to rise further in the coming years.

Some of the key findings include:

  • The prevalent cases of Psoriasis in the adult population in 7MM was reported to be 35,396 in 2016
  • The prevalence of Psoriasis in 2016 was highest in the United States, followed by the the united kingdom
  • As per the estimates of the researcher, the prevalence of Psoriasis is expected to reach up to 4809 cases in 2020 in Italy
  • In 2016, the prevalent population of Psoriasis was 10,627 cases in the United Kingdom

Phototherapies for Psoriasis Market Share by Therapies

This section focusses on the rate of uptake of the phototherapy for the treatment of psoriasis in the market during the study period from 2016-2027. A detailed historical market analysis has been conducted for Phototherapies for Psoriasis, and currently, the market comprises of broad band ultraviolet, psoralen ultraviolet, low-level light/laser therapy, red light, blue light, and other different light and laser sources are available as the first line to third line therapies depend up on the severity and localized part of psoriasis. Other research and development activities are set to add more combination therapies with phototherapy includes the addition of topical agents, vitamin analogues and various systemic therapeutic candidates. This combinations and various laser sourced treatment for psoriasis reached the market and expand its global reach. Projected current scenario and future scope for the treatment of psoriasis with phototherapy from 2016-2027.

Phototherapy for Psoriasis: 7 Major Market Analysis

This part of the Phototherapy for Psoriasis report encloses the detailed analysis of market size in the US, EU5 countries for a period of 2016-2027. The United States had the highest market size of Phototherapy for Psoriasis in 2016, which accounts for approximately 55.71% of the total 7MM market. The market was divide based on the phototherapy type and by end user application.
Epidemiology segmentation of Psoriasis

The report comprises of epidemiology section of the total prevalent population by region wise, total diagnosed prevalent population, Severity specific diagnosed and treatable population by therapies and treatable population segmentation by the use of phototherapy across the 7MM regions.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis of a team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast covering 7MM from 2016-2027.
  • Segment level epidemiology and market split for Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast.
  • The thorough assessment of market, current trends & future scope along with upcoming combination with Phototherapies for Psoriasis.
  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and RoW) from 2016-2027 and detailed historical and forecasted Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast market trends.
  • Thorough market distribution based on market share for Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast.

Reasons to buy:

  • The report will help in developing business strategies by understanding trends shaping and driving the Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast market.
  • To understand the future market scenario in the Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast market and Insightful review of the key market drivers and barriers.
  • Organize sales and marketing efforts by identifying the best opportunities for Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Rest of the world.
  • Identification of future scope in market will help in devising strategies that will help in getting ahead of competitors.
Note: Product cover images may vary from those shown
2 of 2

1 Key Insights

2 Rosacea: Market Overview at a Glance
2.1 Total Market Share (%) Distribution of phototherapy for psoriasis in 2016
2.2 Total Market Share (%) Distribution of phototherapy for psoriasis in 2027

3 Introduction

4 Disease Background and Overview: Psoriasis
4.1 Classification of Psoriasis
4.2 Signs and symptoms
4.3 Risk Factors
4.4 Pathogenesis
4.5 Comorbidities of Psoriasis
4.6 Biomarkers
Soluble Biomarkers
Tissue-Associated Biomarkers
Other Biomarkers

5 Diagnosis
5.1 Differential Diagnosis

6 Epidemiology and Patient Population
6.1 Key Findings

7 Total Prevalent Patient Population of Psoriasis in the US & EU5

8 Total Treatable Patient Population of Psoriasis by Phototherapies in the US and EU5

9 Country Wise-Epidemiology of Psoriasis
9.1 United States

  • Total Prevalent Population of Psoriasis in the United States
  • Total Diagnosed Prevalent Population of Psoriasis in the United States
  • Severity Specific Diagnosed Prevalent Population of Psoriasis in the United States
  • Treatable Population of Psoriasis by Therapies in the United States
  • Treatable Population of Psoriasis by Phototherapies in the United States

9.2 EU5 Countries
9.3 Germany

  • Total Prevalent Population of Psoriasis in Germany
  • Total Diagnosed Prevalent Population of Psoriasis in Germany
  • Severity Specific Diagnosed Prevalence of Psoriasis in Germany
  • Treatable Population of Psoriasis by Therapies in Germany
  • Treatable Population of Psoriasis by Phototherapies in Germany

9.4 France

  • Total Prevalent Population of Psoriasis in France
  • Total Diagnosed Prevalent Population of Psoriasis in France
  • Severity Specific Diagnosed Prevalence of Psoriasis in France
  • Treatable Population of Psoriasis by Therapies in France
  • Treatable Population of Psoriasis by Phototherapies in France

9.5 Italy

  • Total Prevalent Population of Psoriasis in Italy
  • Total Diagnosed Prevalent Population of Psoriasis in Italy
  • Severity Specific Diagnosed Prevalence of Psoriasis in Italy
  • Treatable Population of Psoriasis by Therapies in Italy
  • Treatable Population of Psoriasis by Phototherapies in Italy

9.6 Spain

  • Total Prevalent Population of Psoriasis in Spain
  • Total Diagnosed Prevalent Population of Psoriasis in Spain
  • Severity Specific Diagnosed Prevalence of Psoriasis in Spain
  • Treatable Population of Psoriasis by Therapies in Spain
  • Treatable Population of Psoriasis by Phototherapies in Spain

9.7 United Kingdom

  • Total Prevalent Population of Psoriasis in the United Kingdom
  • Total Diagnosed Prevalent Population of Psoriasis in the United Kingdom
  • Severity Specific Diagnosed Prevalence of Psoriasis in the United Kingdom
  • Treatable Population of Psoriasis by Therapies in the United Kingdom
  • Treatable Population of Psoriasis by Phototherapies in the United Kingdom

10 Treatment
10.1 Nonpharmacologic
10.2 Topical Therapy
10.3 Systemic Therapy
10.4 Biologic Therapy

11 Treatment Algorithm
11.1 Psoriasis clinical guideline: American Academy of Dermatology

  • Biologics therapy
  • Topical Therapy
  • Systemic Therapies
  • Phototherapy
  • NHS Guidelines and management of Psoriasis
  • Guidelines for the management of patients with Psoriasis

12 Phototherapies
12.1 Conditions that can be treated with phototherapy
12.2 What does phototherapy involve?
12.3 Effectiveness of Phototherapy
12.4 Potential side effects of Phototherapy
12.5 Clinical effects of Ultraviolet light and the regulatory pathways
12.6 Phototherapy for Psoriasis
12.7 Phototherapy in combination

13 Current Scenario & Future Scope

14 Unmet Needs

15 Phototherapy for Psoriasis: 7 Major Market Analysis
15.1 Key Findings
15.2 Market Size of Phototherapy for Psoriasis in the US, EU5, and RoW

16 The United States Market Outlook

  • United States Market Size
  • Total Market size of Phototherapy for Psoriasis
  • Market Size by Phototherapy type
  • Market Size by End Users

17 EU5 Market Outlook

  • Total Market size of Phototherapy for Psoriasis
  • Market Size by Phototherapy type
  • Market Size by End Users

18 France Market Size

  • Total Market size of Phototherapy for Psoriasis
  • Market Size by Phototherapy type
  • Market Size by End Users

19 Italy Market Size

  • Total Market size of Phototherapy for Psoriasis
  • Market Size by Phototherapy type
  • Market Size by End Users

20 Spain Market Size

  • Total Market size of Phototherapy for Psoriasis
  • Market Size by Phototherapy type
  • Market Size by End Users

21 United Kingdom Market Size

  • Total Market size of Phototherapy for Psoriasis
  • Market Size by Phototherapy type
  • Market Size by End Users

21 RoW Market Outlook

  • Total Market size of Phototherapy for Psoriasis

22 Market Driver

23 Market Barriers

24 Appendix

  • Report Methodology

25 The Publisher's Capabilities

26 Disclaimer

27 About The Publisher

Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll